• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Canabo Medical Announces 7,500 Patient Study

 

Today, Canabo Medical Inc. (OTC:CAMDF) (TSXV:CMM) announced a major upcoming observational study led by Acadia University's Andrew Davis, Ph.D. 

 

Details

 

The observational study is set to have a sample size of 7,500 Canabo patients, and will be focusing on correlations within three specific areas:

  1. Relation of opioid usage following cannabinoid therapies by patient condition and patient category.

  2. Relation of benzodiazepines usage following cannabinoid therapies by patient condition and patient category.

  3. Change in the quality of patient life measurements following cannabinoid therapies by patient condition and patient category.

This groundbreaking study will be completing participant enrollment in early 2017, and is expected to yield initial results by late 2017. The study's complete findings are expected to be published in 2018.

 

Conclusion

 

For more company information and stock charts for Canabo Medical or other Canadian cannabis companies, be sure to check out their stock profile in our TSXV Listed Marijuana Stocks Database. For the original press release regarding Canabo's study click here. Also don't forget to connect with us on social media using the links to the right of the article so you never miss a marijuana stock update

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.